140 filings
Page 3 of 7
8-K
nbf7t0bl
18 Oct 21
Arch Therapeutics Provides Corporate Update
11:34am
8-K
uap kobi89s3s0wjpj
1 Oct 21
Arch Therapeutics Announces Appointment of Larry Hicks to the Board
4:15pm
8-K
1oiu2y
2 Sep 21
Arch Therapeutics Partners with Lovell Government Services to Expand Distribution Capabilities
10:16am
8-K
k8lmgmj
11 Aug 21
Departure of Directors or Certain Officers
4:11pm
8-K
25r2mt
3 May 21
Arch Therapeutics Appoints Michael S. Abrams its Chief Financial Officer
8:01am
8-K
kvkurgxwkjxfsljtaj5f
19 Apr 21
Arch Therapeutics Provides Corporate Update on Commercialization Efforts and Clinical Results
8:00am
8-K
yu7fgkjb8ku unu4mrz
12 Feb 21
Arch Therapeutics Announces $6.9 Million Private Placement
4:34pm
8-K
cmwlvysacdthv
4 Jan 21
Partnership provides US government facilities access and product distribution support
7:55am
8-K
486iidqut m7iyvx
31 Dec 20
Departure of Directors or Certain Officers
4:25pm
8-K
359m1sy
10 Nov 20
Entry into a Material Definitive Agreement
8:05am
8-K
yn7js jd00bjk7sy8r
11 Aug 20
Regulation FD Disclosure
8:10am
8-K
yril vj9vbd9fdai12
1 Jul 20
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
mnlomk
5 Jun 20
Entry into a Material Definitive Agreement
5:10pm
8-K
lh8ng7yw
27 May 20
Amendments to Articles of Incorporation or Bylaws
11:46am
8-K
xf7444a s7gu
27 Apr 20
Entry into a Material Definitive Agreement
3:51pm
8-K
as1jgwv
13 Apr 20
Arch Therapeutics Receives CE Mark Approval for AC5™ Topical Hemostat in Europe
9:39am
8-K
stpm8w1h 342xj2u1
23 Mar 20
Arch Therapeutics Receives Marketing Clearance from the US FDA Related to the AC5® Topical Gel Supply Chain
8:35am
8-K
9p55qzma01nb2
18 Oct 19
Arch Therapeutics Announces $2.5 Million Registered Direct Offering
3:54pm
8-K/A
asbwtehso8jw7
7 Oct 19
Arch Therapeutics Provides Corporate Update at the 2nd Annual LD Micro Big Apple Conference in Manhattan, NY
4:08pm
8-K
mgy5t0c6i6
7 Oct 19
Arch Therapeutics Provides Corporate Update at the 2nd Annual LD Micro Big Apple Conference in Manhattan, NY
11:56am